Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors interleukin- 7
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- Drug target sets for approved compounds
Most Relevant Literature
- Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain.
- Lrp10 suppresses IL7R limiting CD8 T cell homeostatic expansion and anti-tumor immunity.
- The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
- The miR-15a/16-1 and miR-15b/16-2 clusters regulate early B cell development by limiting IL-7 recept…
- Disseminated Tuberculosis in an Infant with IL-7 Receptor Deficiency.
Most Relevant Clinical Trials
- Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in H…
- IL-7 Receptor Polymorphisms and Immune Recovery With HAART
- Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lu…
- The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer
- Study on Interleukin-7 (CYT107) in HIV Patients
